About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Autoimmune Hepatitis Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT00286663

Autoimmune Hepatitis Study

The purpose of the study is to determine the role special antibodies play in possibly identifying Autoimmune Hepatitis through the following: Identify the response of specific T cells to antibodies a...

Lead sponsor: University of Rochester•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Rochester

Collaborators

National Institutes of Health (NIH)

The object of this protocol is to characterize and monitor auto antigen-specific T cell responses in blood and liver biopsies of patients with anti-SLA/LP or anti-LKM-positive autoimmune hepatitis. The results will provide insight into the pathogenesis of autoimmune hepatitis and the monitoring of auto antigen-specific T cell reactivity in correlation to disease exacerbation and therapy.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female subjects,All ethnic groups, Over 18 years of age, anti-SLA/LP or anti-LKM-positive autoimmune hepatitis

Exclusion Criteria

•Subjects with a hematocrit of \<25

Related studies

Swiss Autoimmune Hepatitis Cohort Study

NCT03146884 · Hepatitis, Autoimmune, Autoimmune Hepatitis

Active Not RecruitingPhase 1/2

Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

NCT02997878 · Cholangitis, Sclerosing, Hepatitis, Autoimmune

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

NCT04376528 · Hepatitis, Autoimmune, Primary Biliary Cholangitis, and more

Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

NCT02874586 · Hepatitis, Autoimmune

WITHDRAWNPhase 3

Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis

NCT02878863 · Hepatitis, Autoimmune

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 9, 2008Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment100

Start dateJan 2006

Last updatedJul 9, 2008

Condition

Hepatitis, Autoimmune

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2008Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions